Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Early detection of specific skin lesions can help identify Birt-Hogg-Dube syndrome and prevent serious complications.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

A specific gene mutation causes different hair defects in Indian monilethrix families.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Early detection and biotin treatment improve outcomes for biotinidase deficiency.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

A specific genetic change in the KRT71 gene causes a hair loss condition in Hereford cattle.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Iodine in rat hair is linked to hair growth.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Improving oral hygiene and quitting smoking can resolve black hairy tongue.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.